About Raptakos Pharma Private Limited
Data last updated:
Raptakos Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Raptakos Brett And Company Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 October 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U15490MH2019PTC331918.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vijay Harishchandra Tagwale and Suhrud Shantilal Jhaveri.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
For more details, the company can be reached via its website raptakos.com.
Company details
Contact details
Raptakos Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is raptakos.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressB – 715 Floor – 7th B Wing Plaza Panchashil Nyaymurti Sitaram Patkar Marg Grant Roa, D, Mumbai, Maharashtra, India – 400007
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Raptakos Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Raptakos Pharma Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Raptakos Pharma Private Limited, buy the company report.
Board of directors of Raptakos Pharma Private Limited
Raptakos Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vijay Harishchandra Tagwale Also directs: Raptakos Solar Private Limited, Montage Laboratories Private Limited, Velacheri Properties Limited and 1 more | Director | 03 Nov 2020 | 5 Years 11 Months | Current |
| Suhrud Shantilal Jhaveri | Director | 19 Oct 2019 | 7 Years 0 Months | Current |
Auditor
Raptakos Pharma Private Limited is audited by SCA AND ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SCA AND ASSOCIATES | FY 2022 | 101174W |
Shareholding
The shareholding of Raptakos Pharma Private Limited is on record for 2 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Raptakos Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Raptakos Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Raptakos Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Raptakos Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Raptakos Pharma Private Limited has 4 board changes on record since 2019: 2 appointments and 2 cessations. The latest: Vijay Harishchandra Tagwale ceased to be Additional Director on 29 Sep 2021.
Frequently asked questions
Raptakos Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 October 2019 (7+ years old) and is registered under CIN U15490MH2019PTC331918.
Raptakos Pharma has 2 current directors:
- Vijay Harishchandra Tagwale - Director
- Suhrud Shantilal Jhaveri - Director
The latest financial statements of Raptakos Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 26 September 2025. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Raptakos Pharma is U15490MH2019PTC331918. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Raptakos Pharma was incorporated on 19 October 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
Vijay Harishchandra Tagwale ceased to be Additional Director on 29 Sep 2021. Shashikant Mahadeo Kane ceased to be Director on 03 Nov 2020. Vijay Harishchandra Tagwale was appointed as Director on 03 Nov 2020. Raptakos Pharma has 4 board changes on record in total.
Raptakos Pharma can be reached through the website raptakos.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Raptakos Pharma is at B – 715 Floor – 7th B Wing Plaza Panchashil Nyaymurti Sitaram Patkar Marg Grant Roa, D, Mumbai, Maharashtra, India – 400007.
Raptakos Pharma operates in the pharma industry, in the drug formulation and development segment.
Raptakos Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Mumbai.